BRCA1 and ovarian cancer: Studies have shown that high methylation levels of BRCA1 and RASSF1A are prevalent in ovarian cancer patients, with 82% of patients exhibiting the same high methylation pattern in serum or plasma BRCA1 and RASSF1A (218).